[18F]Fluciclovine-PET Guided Salvage Lymph Node Dissection Following Radical Prostatectomy

Despite advances in standard-of-care treatment for prostate cancer, including pelvic radiotherapy and radical prostatectomy with lymph node dissection, biochemical recurrence remains a problem with some studies reporting up to 30% of patients with biochemical recurrence at 10-years following treatment. Upon detection of a rise in serum prostate-specific antigen following treatment, clinicians are left with the dilemma of how best to treat these patients. Frequently, these patients are restaged with CT of the abdomen and pelvis or MRI of the pelvis in addition to a nuclear medicine bone scan.
Source: Urology - Category: Urology & Nephrology Authors: Source Type: research